France Polyclonal Antibodies Market Size & Outlook
Related Markets
France polyclonal antibodies market highlights
- The France polyclonal antibodies market generated a revenue of USD 71.7 million in 2023 and is expected to reach USD 109.7 million by 2030.
- The France market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
- In terms of segment, rabbits was the largest revenue generating source in 2023.
- Mouse is the most lucrative source segment registering the fastest growth during the forecast period.
Polyclonal antibodies market data book summary
| Market revenue in 2023 | USD 71.7 million |
| Market revenue in 2030 | USD 109.7 million |
| Growth rate | 6.3% (CAGR from 2023 to 2030) |
| Largest segment | Rabbits |
| Fastest growing segment | Mouse |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Rabbits, Goats, Sheep, Mouse |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Abcam PLC, Proteintech Group, Bio-Rad Laboratories Inc, Beach Energy Ltd, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, France accounted for 4.6% of the global polyclonal antibodies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany polyclonal antibodies market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 109.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polyclonal Antibodies Market Scope
Polyclonal Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Beach Energy Ltd | View profile | 214 | 80 Flinders Street, Level 8, Adelaide, SA, Australia, 5000 | https://www.beachenergy.com.au |
| Proteintech Group | View profile | 251-500 | Rosamond, Illinois, United States, North America | http://www.ptglab.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
France polyclonal antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polyclonal antibodies market will help companies and investors design strategic landscapes.
Rabbits was the largest segment with a revenue share of 50.49% in 2023. Horizon Databook has segmented the France polyclonal antibodies market based on rabbits, goats, sheep, mouse covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to France polyclonal antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France polyclonal antibodies market databook
-
Our clientele includes a mix of polyclonal antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France polyclonal antibodies market , including forecasts for subscribers. This country databook contains high-level insights into France polyclonal antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France polyclonal antibodies market size, by source, 2018-2030 (US$M)
France Polyclonal Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
